AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE
Live / Allowed — Published for opposition (as of 17 Feb 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 26 Aug 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99358160
- Mark type
- Design + words
- Filed
- 26 Aug 2025
- Published for opposition
- 17 Feb 2026
- Attorney of record
- Nancy Sabarra
Goods and services
- Class 005 — Pharmaceuticals: Vaccines
Owner
- Seqirus Inc., Holly Springs, NC, US
- Seqirus Inc., Holly Springs, NC, US
Prosecution history
- 17 Feb 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Feb 2026 — PUBLISHED FOR OPPOSITION
- 11 Feb 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jan 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 19 Jan 2026 — ASSIGNED TO EXAMINER
- 18 Jan 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 18 Jan 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 22 Sept 2025 — PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
- 16 Sept 2025 — ASSIGNED TO LIE
- 09 Sept 2025 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 26 Aug 2025 — APPLICATION FILING RECEIPT MAILED
- 26 Aug 2025 — NEW APPLICATION ENTERED